Near real‐time adverse drug reaction surveillance within population‐based health networks: methodology considerations for data accrual
ConclusionsNear real‐time sequential safety surveillance is feasible, but several barriers warrant attention. Data quality review of each data extract was necessary. Although signal detection was not affected by delay in analysis, when using a historical control group differential accrual between exposure and outcomes may theoretically bias near real‐time risk estimates towards the null, causing failure to detect a signal. Copyright © 2013 John Wiley & Sons, Ltd.
Source: Pharmacoepidemiology and Drug Safety - Category: Drugs & Pharmacology Authors: Taliser R. Avery, Martin Kulldorff, Yury Vilk, Lingling Li, T. Craig Cheetham, Sascha Dublin, Robert L. Davis, Liyan Liu, Lisa Herrinton, Jeffrey S. Brown Tags: Original Report Source Type: research
More News: Divalproex Sodium | Drugs & Pharmacology | Emergency Medicine | History of Medicine | Statistics | Study